Beiley Biofund (7882) Stock Overview
A principal investment firm specializing in early stage investments. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
7882 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Beiley Biofund Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$21.60 |
| 52 Week High | NT$33.55 |
| 52 Week Low | NT$17.60 |
| Beta | 0 |
| 1 Month Change | -4.64% |
| 3 Month Change | -10.37% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -6.70% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7882 | TW Capital Markets | TW Market | |
|---|---|---|---|
| 7D | 0% | 13.3% | 0.5% |
| 1Y | n/a | 72.9% | 106.7% |
Return vs Industry: Insufficient data to determine how 7882 performed against the TW Capital Markets industry.
Return vs Market: Insufficient data to determine how 7882 performed against the TW Market.
Price Volatility
| 7882 volatility | |
|---|---|
| 7882 Average Weekly Movement | 3.5% |
| Capital Markets Industry Average Movement | 6.2% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in TW Market | 12.2% |
| 10% least volatile stocks in TW Market | 2.6% |
Stable Share Price: 7882 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: Insufficient data to determine 7882's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | n/a | Che Hsu | www.beileybiofund.com |
Beiley Biofund Inc. is a principal investment firm specializing in early stage investments. It prefers to invest in life sciences by partnering with innovators to develop breakthrough therapies and technologies. It typically invests in biotechnology and medical innovation.
Beiley Biofund Inc. Fundamentals Summary
| 7882 fundamental statistics | |
|---|---|
| Market cap | NT$4.43b |
| Earnings (TTM) | NT$142.16m |
| Revenue (TTM) | NT$210.55m |
Is 7882 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7882 income statement (TTM) | |
|---|---|
| Revenue | NT$210.55m |
| Cost of Revenue | NT$0 |
| Gross Profit | NT$210.55m |
| Other Expenses | NT$68.39m |
| Earnings | NT$142.16m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.69 |
| Gross Margin | 100.00% |
| Net Profit Margin | 67.52% |
| Debt/Equity Ratio | 0% |
How did 7882 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/06 14:56 |
| End of Day Share Price | 2026/06/05 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Beiley Biofund Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.